The research conducted by Professor Zou Zui and his team focuses on the immunoregulatory mechanisms in sepsis. As a ...
BackgroundSepsis is a complex clinical syndrome characterized by dysregulated immune responses, systemic inflammation, and multi-organ dysfunction. It ...
New research shows weightlifting may outperform running in controlling blood sugar and preventing obesity, offering key ...
The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...
PMA submission targeted for Q1 2026 following positive Tigris results and ongoing FDA interactionsCompany to host Corporate Update call on ...
SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments ...
A study reveals how a broken brain connection between the ARAS and parahippocampal gyrus may predict and explain delirium ...
Maternal deaths in Afghanistan rise due to bans on women's education and healthcare, impacting skilled support during childbirth.
The Abortion Care in Victoria report is not progress – it is propaganda promoted to the public as ‘reproductive justice’.
DelveInsight's Endometrial Cancer Market Insights report includes a comprehensive understanding of current treatment practices, endometrial cancer emerging drugs, market share of individual therapies, ...
Diana Jupp, CEO of Pancreatic Cancer UK, said: “The breath test has the potential to revolutionise the early detection of pancreatic cancer. It is, undoubtedly, the most significant step toward a ...
Zacks Small Cap Research on MSN
EDSA: EB05 Reduces Risk of Death 25% in Phase 3 ARDS Trial…
EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Positive Phase 3 Results for EB05 in ARDS On October 28, 2025, Edesa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results